论文部分内容阅读
Charcot-Marie-Tooth (CMT) neuropathy is the most common hereditary cause of neuropathy.Diagnosis is usually not made during the childhood but in adolescence or late adulthood.It is reported in the literature that some neurotoxic chemotherapeutical agents can reveal an asymptomatic CMT IA hereditary neuropathy.To our knowledge,we report here the first case of CMT IA revealed in a 55-year-old woman after the administration of docetaxel/trastuzumab/pertuzumab for metastatic breast cancer.This case stresses again the necessity to obtain a complete personal and familial anamnesis and to perform a neurologic examination before the administration of neurotoxic chemotherapeutical agents to prevent the clinical expression of these hereditary neuropathies.
Charcot-Marie-Tooth (CMT) neuropathy is the most common hereditary cause of neuropathy. Diagosis is usually not made during the childhood but in adolescence or late adulthood. It is reported in the literature that some of the neurotoxic chemotherapeutic agents can reveal an asymptomatic CMT IA hereditary neuropathy.To our knowledge, we report here the first case of CMT IA revealed in a 55-year-old woman after the administration of docetaxel / trastuzumab / pertuzumab for metastatic breast cancer. This case again again the necessity to obtain a complete personal and familial anamnesis and to perform a neurologic examination before the administration of neurotoxic chemotherapeutical agents to prevent the clinical expression of these hereditary neuropathies.